Literature DB >> 9423936

5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.

D Marona-Lewicka1, D E Nichols.   

Abstract

The possible effect of 5-HT2A/2C receptor agonists on an amphetamine-induced behavioral response was examined using the two-lever drug discrimination paradigm. The experiments were designed to investigate an interaction of the hallucinogenic 5-HT2A/2C agonists lysergic acid diethylamide (LSD) and 2,5-dimethoxy-4-iodoamphetamine (DOI), with the discriminative stimulus elicited by a relatively low dose of (+)-amphetamine (1.35 micromol/kg, 0.25 mg/kg, which produced approximately 50% selection of the drug lever). DOI and LSD did not produce amphetamine-like responding at any dose tested or time of administration. However, LSD alone was able to induce a drug-appropriate response in two of nine amphetamine-trained rats. Simultaneous administration of DOI or LSD with amphetamine was not significantly different from the response produced by amphetamine alone. Pre-administration of DOI (3 hr) or of LSD (2 hr) before amphetamine, however, evoked significant enhancement of the amphetamine cue. The results suggest that the enhanced behavioral response to amphetamine may be due either to an increased sensitivity of dopaminergic neurons in the mesolimbic area, or to an enhanced release of dopamine by amphetamine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423936     DOI: 10.1016/s0028-3908(97)00106-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys.

Authors:  Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2016-05-27       Impact factor: 4.492

3.  Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Authors:  Danuta Marona-Lewicka; Ronald A Thisted; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2005-02-19       Impact factor: 4.530

4.  Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Authors:  Adam L Halberstadt
Journal:  Pharmacol Biochem Behav       Date:  2016-01-15       Impact factor: 3.533

5.  Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.

Authors:  Danuta Marona-Lewicka; Benjamin R Chemel; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

Review 6.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

7.  Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD.

Authors:  Timothy Lawn; Ottavia Dipasquale; Alexandros Vamvakas; Ioannis Tsougos; Mitul A Mehta; Matthew A Howard
Journal:  Psychopharmacology (Berl)       Date:  2022-03-24       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.